Drug Shortage Report for CEFTIN
| Report ID | 162402 |
| Drug Identification Number | 02212307 |
| Brand name | CEFTIN |
| Common or Proper name | cefuroxime axetil for oral suspension |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFUROXIME |
| Strength(s) | 125MG |
| Dosage form(s) | GRANULES FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 100ML |
| ATC code | J01DC |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-08 |
| Estimated end date | 2022-09-02 |
| Actual end date | 2022-08-23 |
| Shortage status | Resolved |
| Updated date | 2022-08-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-08-24 | French | Compare |
| v3 | 2022-08-24 | English | Compare |
| v2 | 2022-06-10 | French | Compare |
| v1 | 2022-06-10 | English | Compare |
Showing 1 to 4 of 4